178 related articles for article (PubMed ID: 27268459)
41. Evaluation of a comprehensive transcranial doppler screening program for children with sickle cell anemia.
McCarville MB; Goodin GS; Fortner G; Li CS; Smeltzer MP; Adams R; Wang W
Pediatr Blood Cancer; 2008 Apr; 50(4):818-21. PubMed ID: 18085672
[TBL] [Abstract][Full Text] [Related]
42. Sickle cell disorder, beta-globin gene cluster haplotypes and alpha-thalassemia in neonates and adults from Guadeloupe.
Kéclard L; Romana M; Lavocat E; Saint-Martin C; Berchel C; Mérault G
Am J Hematol; 1997 May; 55(1):24-7. PubMed ID: 9136913
[TBL] [Abstract][Full Text] [Related]
43. β-globin gene cluster haplotypes in sickle cell patients from Panamá.
Rusanova I; Cossio G; Moreno B; Javier Perea F; De Borace RG; Perea M; Escames G; Acuña-Castroviejo D
Am J Hum Biol; 2011; 23(3):377-80. PubMed ID: 21387457
[TBL] [Abstract][Full Text] [Related]
44. Utilization of TCD screening for primary stroke prevention in children with sickle cell disease.
Armstrong-Wells J; Grimes B; Sidney S; Kronish D; Shiboski SC; Adams RJ; Fullerton HJ
Neurology; 2009 Apr; 72(15):1316-21. PubMed ID: 19365052
[TBL] [Abstract][Full Text] [Related]
45. Clinical, hematological, and molecular characterization of sickle cell anemia pediatric patients from two different cities in Brazil.
Lyra IM; Gonçalves MS; Braga JA; Gesteira Mde F; Carvalho MH; Saad ST; Figueiredo MS; Costa FF
Cad Saude Publica; 2005; 21(4):1287-90. PubMed ID: 16021267
[TBL] [Abstract][Full Text] [Related]
46. Transcranial Doppler ultrasonography in children with sickle cell anemia: Clinical and laboratory correlates for elevated blood flow velocities.
Lagunju I; Sodeinde O; Brown B; Akinbami F; Adedokun B
J Clin Ultrasound; 2014 Feb; 42(2):89-95. PubMed ID: 24166013
[TBL] [Abstract][Full Text] [Related]
47. Sickle cell anemia. Beta s gene cluster haplotypes as genetic markers for severe disease expression.
Powars D; Hiti A
Am J Dis Child; 1993 Nov; 147(11):1197-202. PubMed ID: 8237915
[TBL] [Abstract][Full Text] [Related]
48. Alpha Thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia.
Hsu LL; Miller ST; Wright E; Kutlar A; McKie V; Wang W; Pegelow CH; Driscoll C; Hurlet A; Woods G; Elsas L; Embury S; Adams RJ;
J Pediatr Hematol Oncol; 2003 Aug; 25(8):622-8. PubMed ID: 12902915
[TBL] [Abstract][Full Text] [Related]
49. G6PD deficiency and absence of α-thalassemia increase the risk for cerebral vasculopathy in children with sickle cell anemia.
Joly P; Garnier N; Kebaili K; Renoux C; Dony A; Cheikh N; Renard C; Ceraulo A; Cuzzubbo D; Pondarré C; Martin C; Pialoux V; Francina A; Bertrand Y; Connes P
Eur J Haematol; 2016 Apr; 96(4):404-8. PubMed ID: 26072930
[TBL] [Abstract][Full Text] [Related]
50. Sickle cell disease.
Strouse J
Handb Clin Neurol; 2016; 138():311-24. PubMed ID: 27637966
[TBL] [Abstract][Full Text] [Related]
51. Avascular necrosis of the hip in children with sickle cell disease and high Hb F: magnetic resonance imaging findings and influence of alpha-thalassemia trait.
Adekile AD; Gupta R; Yacoub F; Sinan T; Al-Bloushi M; Haider MZ
Acta Haematol; 2001; 105(1):27-31. PubMed ID: 11340250
[TBL] [Abstract][Full Text] [Related]
52. Molecular characterization of alpha-thalassemia determinants, beta-thalassemia alleles, and beta S haplotypes among Kuwaiti Arabs.
Adekile AD; Gu LH; Baysal E; Haider MZ; al-Fuzae L; Aboobacker KC; al-Rashied A; Huisman TH
Acta Haematol; 1994; 92(4):176-81. PubMed ID: 7701914
[TBL] [Abstract][Full Text] [Related]
53. Sickle cell anemia and α-thalassemia: a modulating factor in homozygous HbS/S patients in Oman.
Hassan SM; Al Muslahi M; Al Riyami M; Bakker E; Harteveld CL; Giordano PC
Eur J Med Genet; 2014; 57(11-12):603-6. PubMed ID: 25266642
[TBL] [Abstract][Full Text] [Related]
54. Influence of alpha-thalassemia on cholelithiasis in SS patients with elevated Hb F.
Haider MZ; Ashebu S; Aduh P; Adekile AD
Acta Haematol; 1998 Dec; 100(3):147-50. PubMed ID: 9858792
[TBL] [Abstract][Full Text] [Related]
55. Alpha-thalassemia is associated with a decreased occurrence and a delayed age-at-onset of albuminuria in sickle cell anemia patients.
Nebor D; Broquere C; Brudey K; Mougenel D; Tarer V; Connes P; Elion J; Romana M
Blood Cells Mol Dis; 2010 Aug; 45(2):154-8. PubMed ID: 20598923
[TBL] [Abstract][Full Text] [Related]
56. Defining stroke risk in children with sickle cell anaemia.
Hoppe C
Br J Haematol; 2005 Mar; 128(6):751-66. PubMed ID: 15755278
[TBL] [Abstract][Full Text] [Related]
57. Association of classical markers and establishment of the dyslipidemic sub-phenotype of sickle cell anemia.
Aleluia MM; da Guarda CC; Santiago RP; Fonseca TC; Neves FI; de Souza RQ; Farias LA; Pimenta FA; Fiuza LM; Pitanga TN; Ferreira JR; Adorno EV; Cerqueira BA; Gonçalves MS
Lipids Health Dis; 2017 Apr; 16(1):74. PubMed ID: 28399852
[TBL] [Abstract][Full Text] [Related]
58. Beta-globin gene cluster haplotypes and alpha-thalassemia in sickle cell disease patients from Trinidad.
Jones-Lecointe A; Smith E; Romana M; Gilbert MG; Charles WP; Saint-Martin C; Kéclard L
Am J Hum Biol; 2008; 20(3):342-4. PubMed ID: 18257074
[TBL] [Abstract][Full Text] [Related]
59. Annual stroke incidence in Nigerian children with sickle cell disease and elevated TCD velocities treated with hydroxyurea.
Lagunju I; Brown BJ; Oyinlade AO; Asinobi A; Ibeh J; Esione A; Sodeinde OO
Pediatr Blood Cancer; 2019 Mar; 66(3):e27252. PubMed ID: 29797633
[TBL] [Abstract][Full Text] [Related]
60. Beta-globin gene cluster haplotype and alpha-thalassemia do not correlate with the acute clinical manifestations of sickle cell disease in children.
de Montalembert M; Maier-Redelsperger M; Girot R; Belloy M; Vilmer E; Ducrocq R; Guidal C; Elion J
Blood; 1993 Oct; 82(8):2595-6. PubMed ID: 8400306
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
